雷氏肌肉瘤治疗方法和未来的方向
Candace L Haddox1, David J Papke2, César Serrano3
1Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.
Hematology/oncology clinics of North America
|May 23, 2025
概括
溶性肌肉瘤 (LMS) 是一种罕见的癌症,起源于光滑肌肉. 分子理解的进步正在改善诊断,并指导这些复杂恶性瘤的新疗法.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 遗传学 遗传学 是一个
背景情况:
- 溶性肌肉瘤 (LMS) 是来自光滑肌肉组织的侵略性介质细胞瘤.
- 常见的起源地点包括子宫,尾和四肢,临床表现各不相同.
- 由于LMS的异质性,最佳管理需要采用多学科的方法.
研究的目的:
- 为了提供莱奥米索尔科马 (LMS) 生物学和临床管理的全面概述.
- 突出分子表征,诊断和治疗策略的最新进展.
- 强调专家多学科护理对LMS患者的重要性.
主要方法:
- 对LMS呈现,诊断和分子特征的当前文献的综述.
- 对最近完成和正在进行的临床试验数据的分析.
- 综合有关新型预后因素和全身疗法的信息.
主要成果:
- 分子表征提高了诊断的准确性,并确定了新的预后标志物.
- 目前正在进行的临床试验正在完善LMS的管理协议.
- 多学科护理对于应对复杂的LMS病例至关重要.
结论:
- 溶性肌肉肉瘤 (LMS) 需要根据原产地和分子特征进行量身定制的治疗.
- 对LMS生物学和治疗的持续研究对于改善患者的治疗结果至关重要.
- 涉及专业团队的综合护理模式是优化LMS治疗的关键.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


